eccogene glp 1

eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases Non‐clinical and first‐in‐human characterization of

Name: eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases Non‐clinical and first‐in‐human characterization of
Brand: 2m-capital.com
SKU: 65105710312
Price: 26.55 USD
Availability: InStock
Rating: 4.1665 (11 reviews)

SKU: 65105710312

4.2

EUR26.55 EUR56.55

Pay in 4 interest-free payments of $6.64 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 16 - Nov 21

Description

Each one contributes to a safer, more comfortable injection

Available size: 50mg

Currently, the absence of specific diagnostic thresholds makes it challenging to accurately distinguish whether patients are in the stages of simple prostatitis, precancerous lesions, or early PCa